BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10813202)

  • 1. Exercise and interstitial lung disease.
    Markovitz GH; Cooper CB
    Curr Opin Pulm Med; 1998 Sep; 4(5):272-80. PubMed ID: 10813202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary Vascular and Right Ventricular Burden During Exercise in Interstitial Lung Disease.
    Oliveira RKF; Waxman AB; Hoover PJ; Dellaripa PF; Systrom DM
    Chest; 2020 Jul; 158(1):350-358. PubMed ID: 32173491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of hypoxemia and pulmonary mechanics in exercise limitation in interstitial lung disease.
    Harris-Eze AO; Sridhar G; Clemens RE; Zintel TA; Gallagher CG; Marciniuk DD
    Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):994-1001. PubMed ID: 8887597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current best practice in rehabilitation in interstitial lung disease.
    Nakazawa A; Cox NS; Holland AE
    Ther Adv Respir Dis; 2017 Feb; 11(2):115-128. PubMed ID: 28150539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventilation distribution as a contributor to the functional exercise capacity in patients with systemic sclerosis-associated interstitial lung disease without pulmonary hypertension.
    Andrade FM; Oliveira AD; Lopes AJ
    Braz J Med Biol Res; 2019; 52(8):e8513. PubMed ID: 31365695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary vascular response patterns during exercise in interstitial lung disease.
    Degani-Costa LH; Levarge B; Digumarthy SR; Eisman AS; Harris RS; Lewis GD
    Eur Respir J; 2015 Sep; 46(3):738-49. PubMed ID: 25976688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exertional dyspnoea in interstitial lung diseases: the clinical utility of cardiopulmonary exercise testing.
    Bonini M; Fiorenzano G
    Eur Respir Rev; 2017 Jan; 26(143):. PubMed ID: 28223398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiological mechanisms of exertional breathlessness in chronic obstructive pulmonary disease and interstitial lung disease.
    Jensen D; Schaeffer MR; Guenette JA
    Curr Opin Support Palliat Care; 2018 Sep; 12(3):237-245. PubMed ID: 30074922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise limitation in interstitial lung disease - mechanisms, significance and therapeutic options.
    Holland AE
    Chron Respir Dis; 2010; 7(2):101-11. PubMed ID: 20056733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qualitative aspects of exertional dyspnea in patients with interstitial lung disease.
    O'Donnell DE; Chau LK; Webb KA
    J Appl Physiol (1985); 1998 Jun; 84(6):2000-9. PubMed ID: 9609795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical exercise testing in interstitial lung disease.
    Marciniuk DD; Gallagher CG
    Clin Chest Med; 1994 Jun; 15(2):287-303. PubMed ID: 8088094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung volumes and expiratory flow limitation during exercise in interstitial lung disease.
    Marciniuk DD; Sridhar G; Clemens RE; Zintel TA; Gallagher CG
    J Appl Physiol (1985); 1994 Aug; 77(2):963-73. PubMed ID: 8002554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology of activity limitation in patients with interstitial lung disease.
    Hansen JE; Wasserman K
    Chest; 1996 Jun; 109(6):1566-76. PubMed ID: 8769513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinguishing pulmonary hypertension in interstitial lung disease by ventilation and perfusion defects measured by cardiopulmonary exercise testing.
    Armstrong HF; Thirapatarapong W; Dussault NE; Bartels MN
    Respiration; 2013; 86(5):407-13. PubMed ID: 23735701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms and consequences of excess exercise ventilation in fibrosing interstitial lung disease.
    Plachi F; Balzan FM; Gass R; Käfer KD; Santos AZ; Gazzana MB; Neder JA; Berton DC
    Respir Physiol Neurobiol; 2024 Jul; 325():104255. PubMed ID: 38555042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary rehabilitation in interstitial lung diseases.
    Makhdami N; Farooqi M; Thom-Fernandes C; Raghavan NG
    Curr Opin Pulm Med; 2020 Sep; 26(5):470-476. PubMed ID: 32769674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of abnormal lung perfusion in excessive exercise ventilation in chronic heart failure.
    Wada O; Asanoi H; Miyagi K; Ishizaka S; Kameyama T; Seto H; Sasayama S
    Am Heart J; 1993 Mar; 125(3):790-8. PubMed ID: 8438708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evidence of benefits of exercise training in interstitial lung disease: a randomised controlled trial.
    Dowman LM; McDonald CF; Hill CJ; Lee AL; Barker K; Boote C; Glaspole I; Goh NSL; Southcott AM; Burge AT; Gillies R; Martin A; Holland AE
    Thorax; 2017 Jul; 72(7):610-619. PubMed ID: 28213592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging concepts in the evaluation of ventilatory limitation during exercise: the exercise tidal flow-volume loop.
    Johnson BD; Weisman IM; Zeballos RJ; Beck KC
    Chest; 1999 Aug; 116(2):488-503. PubMed ID: 10453881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exercise Pathophysiology in Interstitial Lung Disease.
    Molgat-Seon Y; Schaeffer MR; Ryerson CJ; Guenette JA
    Clin Chest Med; 2019 Jun; 40(2):405-420. PubMed ID: 31078218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.